Back

SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation

2 September 2024 (11:22 - 11:34)
Organised by: Logo
Congress Presentation Part of: HOT LINE 10 Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masaharu Masuda

Kansai Rosai Hospital, Amagasaki (Japan)

8 More presentations in this session

Presentation thumbnail
SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation
Doctor R. Dulai (London, GB)
Slides Video
Presentation thumbnail
Discussant review - SHAM-PVI
Doctor N. Dagres (Berlin, DE)
Slides Video
Presentation thumbnail
Panel discussion - SHAM-PVI
Video
Presentation thumbnail
Discussant review - SUPPRESS-AF
Professor H. Puererfellner (Linz, AT)
Slides Video
Presentation thumbnail
Panel discussion - SUPPRESS-AF
Video

Access the full session

Session thumbnail
HOT LINE 10
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 11:22 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study
thumbnail
Congress Session
HOT LINE 10
thumbnail
Congress Presentation
The efficacy of low-voltage-area ablation enhances in patients with advanced left atrial enlargement: a subanalysis of SUPPRESS-AF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources